GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Bridge Science Inc (OTCPK:BGES) » Definitions » COGS-to-Revenue

Bio-Bridge Science (Bio-Bridge Science) COGS-to-Revenue : 0.56 (As of Sep. 2011)


View and export this data going back to 2005. Start your Free Trial

What is Bio-Bridge Science COGS-to-Revenue?

Bio-Bridge Science's Cost of Goods Sold for the three months ended in Sep. 2011 was $0.01 Mil. Its Revenue for the three months ended in Sep. 2011 was $0.02 Mil.

Bio-Bridge Science's COGS to Revenue for the three months ended in Sep. 2011 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bio-Bridge Science's Gross Margin % for the three months ended in Sep. 2011 was 44.44%.


Bio-Bridge Science COGS-to-Revenue Historical Data

The historical data trend for Bio-Bridge Science's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Bridge Science COGS-to-Revenue Chart

Bio-Bridge Science Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
COGS-to-Revenue
Get a 7-Day Free Trial 0.50 0.67 0.76 0.44 0.98

Bio-Bridge Science Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 2.76 0.53 0.57 0.56

Bio-Bridge Science COGS-to-Revenue Calculation

Bio-Bridge Science's COGS to Revenue for the fiscal year that ended in Dec. 2010 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.095 / 0.097
=0.98

Bio-Bridge Science's COGS to Revenue for the quarter that ended in Sep. 2011 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.01 / 0.018
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Bridge Science  (OTCPK:BGES) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bio-Bridge Science's Gross Margin % for the three months ended in Sep. 2011 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.01 / 0.018
=44.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Bio-Bridge Science COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio-Bridge Science's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Bridge Science (Bio-Bridge Science) Business Description

Traded in Other Exchanges
N/A
Address
PO Box 168081, Chicago, IL, USA, 60616
Bio-Bridge Science Inc is a biotech company focused on the commercial development of biological products for the prevention and treatment of human diseases and manufacturing and sales of materials in producing vaccines. It develop products in respect to HIV vaccine, a vaccine to prevent AIDS; a colon cancer therapeutic vaccine; and an HPV vaccine to prevent cervical cancer.

Bio-Bridge Science (Bio-Bridge Science) Headlines

No Headlines